[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK96177A - 4-androsten-3-oner og fremgangsmade til fremstilling heraf - Google Patents

4-androsten-3-oner og fremgangsmade til fremstilling heraf

Info

Publication number
DK96177A
DK96177A DK96177A DK96177A DK96177A DK 96177 A DK96177 A DK 96177A DK 96177 A DK96177 A DK 96177A DK 96177 A DK96177 A DK 96177A DK 96177 A DK96177 A DK 96177A
Authority
DK
Denmark
Prior art keywords
androsten
oner
preparation
Prior art date
Application number
DK96177A
Other languages
English (en)
Other versions
DK146856B (da
DK146856C (da
Inventor
R Philippson
B Krieger
J Casals-Stenzel
U Kerb
W Losert
K Prezewowsky
R Wiechert
D Bittler
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762609695 external-priority patent/DE2609695A1/de
Priority claimed from DE19762609694 external-priority patent/DE2609694C3/de
Priority claimed from DE19762627187 external-priority patent/DE2627187A1/de
Priority claimed from DE19762627186 external-priority patent/DE2627186A1/de
Priority claimed from DE19762644427 external-priority patent/DE2644427A1/de
Priority claimed from DE19762646043 external-priority patent/DE2646043C2/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK96177A publication Critical patent/DK96177A/da
Priority to DK403382A priority Critical patent/DK403382A/da
Publication of DK146856B publication Critical patent/DK146856B/da
Application granted granted Critical
Publication of DK146856C publication Critical patent/DK146856C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96177A 1976-03-05 1977-03-04 Analogifremgangsmaade til fremstilling af 17alfa-(3-hydroxypropyl)-17beta-hydroxy-4-gonen-3-oner DK146856C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK403382A DK403382A (da) 1976-03-05 1982-09-09 Fremgangsmaade til fremstilling af 4-androsten-3-oner

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
DE19762609695 DE2609695A1 (de) 1976-03-05 1976-03-05 7-substituierte 4-androsten-3-one und verfahren zu ihrer herstellung
DE2609694 1976-03-05
DE2609695 1976-03-05
DE19762609694 DE2609694C3 (de) 1976-03-05 1976-03-05 17 a-(3-Hydroxpropyl)-17 ß- hydroxy-7 a-thioalkanoyl-4-androsten- 3-one und Verfahren zu deren Herstellung
DE2627186 1976-06-16
DE19762627187 DE2627187A1 (de) 1976-06-16 1976-06-16 7-substituierte 4-androsten-3-one und verfahren zu ihrer herstellung ii
DE2627187 1976-06-16
DE19762627186 DE2627186A1 (de) 1976-03-05 1976-06-16 7-substituierte 4-androsten-3-one und verfahren zu ihrer herstellung iii
DE2644427 1976-09-30
DE19762644427 DE2644427A1 (de) 1976-09-30 1976-09-30 17 beta-hydroxy-17 alpha-(3-acyloxypropyl)-4.6-androstadien-3-one und deren salze
DE2646043 1976-10-08
DE19762646043 DE2646043C2 (de) 1976-10-08 1976-10-08 7α-Acetylthio-6α-methyl-4-androsten-3-one, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
DK96177A true DK96177A (da) 1977-09-06
DK146856B DK146856B (da) 1984-01-23
DK146856C DK146856C (da) 1984-07-02

Family

ID=27544260

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96177A DK146856C (da) 1976-03-05 1977-03-04 Analogifremgangsmaade til fremstilling af 17alfa-(3-hydroxypropyl)-17beta-hydroxy-4-gonen-3-oner

Country Status (15)

Country Link
US (1) US4118488A (da)
JP (1) JPS52111552A (da)
AT (2) AT365611B (da)
BE (1) BE852089A (da)
CA (1) CA1078826A (da)
CH (1) CH631462A5 (da)
DD (1) DD128659A5 (da)
DK (1) DK146856C (da)
FR (1) FR2342990A1 (da)
GB (1) GB1579298A (da)
IE (1) IE44711B1 (da)
IL (1) IL51586A (da)
LU (1) LU76883A1 (da)
NL (1) NL7702369A (da)
SE (1) SE420732B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53116361A (en) * 1977-03-17 1978-10-11 Mitsubishi Chem Ind Ltd Preparation of 7 acylthioo44enee33oxosteroid
ES469510A1 (es) * 1977-05-16 1978-12-01 Schering Ag Procedimiento para la preparacion de 17beta hidroxi-4-an- drosten-3-onas.
DE3111951A1 (de) * 1981-03-23 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen 7(alpha)-alkoxycarbonyl-15ss-methylen-4-androstene, verfahren zu ihrer herstellung und verwendung als arzneimittel
DE3130644A1 (de) * 1981-07-29 1983-02-17 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue androstan-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
EP0116974B1 (de) * 1983-02-18 1986-10-29 Schering Aktiengesellschaft 11-Beta-Aryl-Estradiene, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
US4552871A (en) * 1983-04-13 1985-11-12 Ciba Geigy Corporation Steroids of the 20-spiroxane series, processes for the manufacture thereof, pharmaceutical preparations containing such compounds and the use of the latter
EA009176B1 (ru) 1995-12-11 2007-12-28 Дж.Д.Серл Энд Ко. Способ получения 7-альфа-карбоксил-9,11-эпоксистероидов и промежуточных продуктов, используемых для их получения, и общий способ эпоксидирования по олефиновым двойным связям
JP2001509792A (ja) 1996-12-11 2001-07-24 ジー．ディー．サール アンド カンパニー ９，１１−エポキシステロイドの製造法ならびに該方法に有用な中間体
US6887991B1 (en) * 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
WO2003082895A2 (en) * 2002-03-22 2003-10-09 Pharmacia & Upjohn Company Process to prepare eplerenone

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3137690A (en) * 1963-09-26 1964-06-16 Searle & Co 17beta-hydroxy-3-oxoandrost-4-en-17alpha-ylpropionaldehyde lactol and delta1, delta6, delta1, 6, 19-nor and 7alpha-acetylthio congeners
DE1250818B (de) * 1963-10-01 1967-09-28 G. D. Searle & Co., Chicago, 111. (V. St. A.) Verfahren zur Herstellung von 3-Oxozl4.Asteroiden
US3798213A (en) * 1971-01-25 1974-03-19 Merck & Co Inc 7 alpha-methyl-20-spiroxane-3-ones and process
US3753979A (en) * 1971-12-06 1973-08-21 Merck & Co Inc Substituted 1,2alpha-methylene-6,7alpha-halomethylene-20-spirox-4-en-3-ones or 3-ols and acyl esters thereof
DE2251476A1 (de) * 1972-10-20 1974-05-02 Hoechst Ag Verfahren zur herstellung von beta(3-keto-7 alpha-thioacyl-17 beta-hydroxy4-androsten-17 alpha -yl)-propionsaeuregamma -lactonen
CH609357A5 (da) * 1973-05-25 1979-02-28 Schering Ag

Also Published As

Publication number Publication date
LU76883A1 (da) 1977-07-11
US4118488A (en) 1978-10-03
ATA141377A (de) 1981-06-15
ATA180980A (de) 1982-07-15
SE7702455L (sv) 1977-09-06
DD128659A5 (de) 1977-11-30
IL51586A0 (en) 1977-05-31
IE44711B1 (en) 1982-03-10
SE420732B (sv) 1981-10-26
NL7702369A (nl) 1977-09-07
CH631462A5 (de) 1982-08-13
FR2342990A1 (fr) 1977-09-30
DK146856B (da) 1984-01-23
FR2342990B1 (da) 1979-03-09
JPS52111552A (en) 1977-09-19
GB1579298A (en) 1980-11-19
IE44711L (en) 1977-09-05
IL51586A (en) 1981-10-30
DK146856C (da) 1984-07-02
CA1078826A (en) 1980-06-03
BE852089A (fr) 1977-09-05
AT365611B (de) 1982-02-10
AT370110B (de) 1983-03-10

Similar Documents

Publication Publication Date Title
DK102177A (da) Aminoalkyl-heterocycliske forbindelser og fremgangsmade til fremstilling deraf
DK248078A (da) Phatalaziner og fremgangsmaade til fremstilling deraf
DK137378A (da) Taeppe og fremgangsmaade til fremstilling deraf
DK508077A (da) Hidtil ukendte spirolactoner og fremgangsmaade til fremstilling deraf
DK454178A (da) Acylanilider og fremgangsmaade til fremstilling deraf
DK372878A (da) Thiadiazolylcephalosporinanaloge og fremgangsmaade til fremstilling deraf
DK319277A (da) Hydroxysuccinimidestere fremgangsmade til fremstilling heraf og anvendelse heraf
DK578777A (da) Antibakterielt mundplejemiddel og fremgangsmaade til fremstilling deraf
DK185079A (da) Azolopyrimidinoner og fremgangsmaade til fremstilling deraf
DK11877A (da) Antracyklinglykosider og fremgangsmade til fremstilling deraf
DK502977A (da) Antracyklinderivat og fremgangsmaade til fremstilling deraf
DK308578A (da) Meningokokvaccine og fremgangsmaade til fremstilling heraf
DK96177A (da) 4-androsten-3-oner og fremgangsmade til fremstilling heraf
DK495578A (da) Quinazolderivater og fremgangsmaade til fremstilling deraf
DK12478A (da) Dithienylalkylaminer og fremgangsmaade til fremstilling deraf
DK122276A (da) Organisk phosphateringsmiddel og fremgangsmade til fremstilling heraf
DK213176A (da) Antraquinon-bis-amidiner og fremgangsmade til fremstilling deraf
DK36577A (da) Mufferor og fremgangsmade til fremstilling heraf
DK554078A (da) Tetrapeptider og fremgangsmaade til fremstilling deraf
DK224279A (da) Polyjodbenzenderivater og fremgangsmaade til fremstilling deraf
DK270279A (da) Cystaminderivater og fremgangsmaade til fremstilling deraf
DK151570C (da) Afsvovlningsmiddel og fremgangsmaade til fremstilling deraf
DK352276A (da) Immunologiske adjuvanser og fremgangsmade til fremstilling deraf
DK54678A (da) Azetidinonderivater og fremgangsmaade til fremstilling deraf
DK213878A (da) 17beta-hydroxy-4-androsten-3-on og fremgangsmaade til fremstilling heraf

Legal Events

Date Code Title Description
PBP Patent lapsed